IL326558A - נוגדנים ממוקדי klk5/7 + th2 ושימושים בהם - Google Patents

נוגדנים ממוקדי klk5/7 + th2 ושימושים בהם

Info

Publication number
IL326558A
IL326558A IL326558A IL32655826A IL326558A IL 326558 A IL326558 A IL 326558A IL 326558 A IL326558 A IL 326558A IL 32655826 A IL32655826 A IL 32655826A IL 326558 A IL326558 A IL 326558A
Authority
IL
Israel
Prior art keywords
klk5
targeting antibodies
targeting
antibodies
Prior art date
Application number
IL326558A
Other languages
English (en)
Original Assignee
Triveni Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Triveni Bio Inc filed Critical Triveni Bio Inc
Publication of IL326558A publication Critical patent/IL326558A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
IL326558A 2023-08-25 2024-08-23 נוגדנים ממוקדי klk5/7 + th2 ושימושים בהם IL326558A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363578959P 2023-08-25 2023-08-25
US202463549274P 2024-02-02 2024-02-02
PCT/US2024/043756 WO2025049346A1 (en) 2023-08-25 2024-08-23 Klk5/7 + th2 targeting antibodies and uses thereof

Publications (1)

Publication Number Publication Date
IL326558A true IL326558A (he) 2026-04-01

Family

ID=94820213

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326558A IL326558A (he) 2023-08-25 2024-08-23 נוגדנים ממוקדי klk5/7 + th2 ושימושים בהם

Country Status (3)

Country Link
AU (1) AU2024333809A1 (he)
IL (1) IL326558A (he)
WO (1) WO2025049346A1 (he)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025166138A1 (en) * 2024-02-02 2025-08-07 Triveni Bio, Inc. Klk5/7 + tslp targeting antibodies and uses thereof
WO2025166146A1 (en) * 2024-02-02 2025-08-07 Triveni Bio, Inc. Klk5/7 + ox40 targeting antibodies and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2050764A1 (en) * 2007-10-15 2009-04-22 sanofi-aventis Novel polyvalent bispecific antibody format and uses thereof
CN119912569A (zh) * 2018-06-29 2025-05-02 艾利妥 抗SIRP-β1抗体及其使用方法
US12312414B2 (en) * 2019-09-18 2025-05-27 Genentech, Inc. Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of use

Also Published As

Publication number Publication date
AU2024333809A1 (en) 2026-02-26
WO2025049346A1 (en) 2025-03-06

Similar Documents

Publication Publication Date Title
EP4172216A4 (en) BIFUNCTIONAL SUPERKINE AND USES THEREOF
IL282736A (he) צימודים של אינטרלאוקין 10 ושימושם
EP2502937A3 (en) Anti-CD 79b Antibodies And Immunoconjugates And Methods Of Use
EP4146704A4 (en) ANTIBODIES DIRECTED AGAINST CLEC12A AND USE THEREOF
PH12022552267A1 (en) Tie2-binding agents and methods of use
IL307267A (he) נוגדני anti-cd122 ושימושיהם
IL315828A (he) נוגדנים כנגד sirp-alpha ושימושים בהם
WO2023014809A9 (en) Cd3 targeting antibodies and uses thereof
EP3930767A4 (en) ANTIBODY-DRUG CONJUGATES COMPRISING ANTI-TM4SF1 ANTIBODIES AND METHODS OF USE THEREOF
IL325624A (he) תצמידים ושימושים בהם
EP4106800A4 (en) BASIC DOMAIN DELETED DNASE1-LIKE 3 AND ITS USES
IL327202A (he) נוגדנים אנטי- cdh17 ושימושים בהם
IL291312A (he) זיווגים נוגדן-תרופה נוגדי-ptcra ושימושם
IL307939A (he) נוגדנים אנטי- clec12aושימושים בהם
CA3302850A1 (en) Klk5/7 + th2 targeting antibodies and uses thereof
EP4490199A4 (en) MODIFIED ANTIBODIES AND THEIR USES
IL312584A (he) נוגדני anti-vista ושימושים בהם
IL310810A (he) נוגדנים אנטי- acvr2a ושימושים בהם
IL307233A (he) נוגדנים אנטי- sema3aושימושים בהם
GB2601793B (en) Thymic constructs and uses thereof
IL326559A (he) נוגדנים ממוקדי klk5/7 + il-13 ושימושים בהם
CA3303016A1 (en) Klk5/7 + il-13 targeting antibodies and uses thereof
GB202303531D0 (en) Antibodies and uses thereof
EP4352106A4 (en) ANTI-UPAR ANTIBODIES AND THEIR USES
EP4180457A4 (en) ANTI-CLDN-18.2 ANTIBODIES AND USE THEREOF